KAIPO LINDSEY: Open Payments
NPI 1184174724 · KANEOHE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 63 payments from 9 companies in 2025. Trend: 2023 $585 · 2024 $934 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $445 |
| AstraZeneca Pharmaceuticals LP | 10 | $264 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $241 |
| Alexion Pharmaceuticals, Inc. | 6 | $142 |
| Vanda Pharmaceuticals Inc. | 5 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Novo Nordisk Inc | 4 | $70 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: VRAYLAR, JOURNAVX, ULTOMIRIS, AIRSUPRA, FARXIGA, JARDIANCE, PONVORY, FANAPT.
Industry payments across HI — which companies pay providers there.
